← All sarcoma trials
Recruiting now—Ages 18 Years and up

The Epithelioid Hemangioendothelioma Registry of the European Reference Network on Rare Adult Solid Cancers (EURACAN)

Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano · NCT06408441 on ClinicalTrials.gov ↗

Bring this to your care team →

Conditions studied

Epithelioid HemangioendotheliomaSarcoma,Soft Tissue

Where it's running22 sites

22 international sites
See the official eligibility language

Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.

Inclusion Criteria:

* New patients managed by the contributing centers with a pathological EHE diagnosis performed or verified by an expert sarcoma pathologist starting from 1 December 2023 onwards and to be performed within 6 months from the registration
* Molecular confirmation of the diagnosis (WWTR1-CAMTA1 or YAP1-TFE3)
* Adult patients (aged ≥ 18 years)

Updated 2026-04-03 on ClinicalTrials.gov. Always confirm current details with the study team or your oncologist.